IMMUNE AUGMENTATIVE THERAPY (IAT) FOR MULTIPLE-SCLEROSIS - A POTENTIALLY HARMFUL METHOD

被引：0

|

作者：

PETTE, M ^{[1
]}

HARTUNG, HP ^{[1
]}

TOYKA, KV ^{[1
]}

机构：

[1] UNIV WURZBURG,NEUROL KLIN,D-97080 WURZBURG,GERMANY

来源：

NERVENARZT | 1994年 / 65卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：878 / 880

页数：3

相关论文

共 50 条

[41] SERUM IMMUNE-COMPLEX IN MULTIPLE-SCLEROSIS
POWIS, PA
CUZNER, ML
DAVISON, AN
BIOCHEMICAL SOCIETY TRANSACTIONS, 1977, 5 (05) : 1420 - 1422
[42] CSF IMMUNE-COMPLEXES IN MULTIPLE-SCLEROSIS
COYLE, PK
NEUROLOGY, 1985, 35 (03) : 429 - 432
[43] IMMUNE-MEDIATED MECHANISMS IN MULTIPLE-SCLEROSIS
FUCHS, D
REIBNEGGER, G
WERNER, ER
WACHTER, H
JOURNAL OF NEUROLOGY, 1990, 237 (02) : 125 - 125
[44] PLASMA CLEANING THERAPY IN MULTIPLE-SCLEROSIS (MS)
NAGASATO, K
SHIBAYAMA, K
KANAZAWA, H
SHIBUYA, N
ARTIFICIAL ORGANS, 1988, 12 (02) : 167 - 168
[45] COPOLYMER-I THERAPY FOR MULTIPLE-SCLEROSIS
ROLAK, LA
CLINICAL NEUROPHARMACOLOGY, 1987, 10 (05) : 389 - 396
[46] PATHOGENESIS AND THERAPY OF MULTIPLE-SCLEROSIS - THE ROLE OF CYTOKINES
WEBER, F
RIECKMANN, P
NERVENARZT, 1995, 66 (02): : 150 - 155
[47] EVIDENCE JUSTIFYING IMMUNOSUPPRESSION THERAPY IN MULTIPLE-SCLEROSIS
MERTIN, J
PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1977, 70 (12): : 871 - 874
[48] SYSTEMIC INTERFERON THERAPY OF MULTIPLE-SCLEROSIS - THE PROS
KNOBLER, RL
NEUROLOGY, 1988, 38 (07) : 58 - 61
[49] CLINICAL EFFECTS OF MULTIPLE-SCLEROSIS THERAPY - REPLY
FELDMAN, RG
NEUROLOGY, 1979, 29 (05) : 760 - 760
[50] TRANSFER-FACTOR THERAPY IN MULTIPLE-SCLEROSIS
BEHAN, PO
MELVILLE, ID
DURWARD, WF
MCGEORGE, AP
BEHAN, WMH
LANCET, 1976, 1 (7967): : 988 - 990

← 1 2 3 4 5 →